151 related articles for article (PubMed ID: 10386715)
1. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up.
Reinders JG; Heijmen BJ; Olofsen-van Acht MJ; van Putten WL; Levendag PC
Radiother Oncol; 1999 Apr; 51(1):35-42. PubMed ID: 10386715
[TBL] [Abstract][Full Text] [Related]
2. Cardiac risk after mediastinal irradiation for Hodgkin's disease.
Glanzmann C; Kaufmann P; Jenni R; Hess OM; Huguenin P
Radiother Oncol; 1998 Jan; 46(1):51-62. PubMed ID: 9488128
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
King V; Constine LS; Clark D; Schwartz RG; Muhs AG; Henzler M; Hutson A; Rubin P
Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):881-9. PubMed ID: 8960517
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.
Dubray B; Henry-Amar M; Meerwaldt JH; Noordijk EM; Dixon DO; Cosset JM; Thames HD
Radiother Oncol; 1995 Sep; 36(3):211-7. PubMed ID: 8532908
[TBL] [Abstract][Full Text] [Related]
8. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
9. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease.
Constine LS; Schwartz RG; Savage DE; King V; Muhs A
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):897-906. PubMed ID: 9369139
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
[TBL] [Abstract][Full Text] [Related]
11. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
[TBL] [Abstract][Full Text] [Related]
12. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
Hancock SL; Donaldson SS; Hoppe RT
J Clin Oncol; 1993 Jul; 11(7):1208-15. PubMed ID: 8315419
[TBL] [Abstract][Full Text] [Related]
13. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
[TBL] [Abstract][Full Text] [Related]
14. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
16. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
17. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience.
Lee CK; Aeppli D; Nierengarten ME
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):169-79. PubMed ID: 10924987
[TBL] [Abstract][Full Text] [Related]
18. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model.
Eriksson F; Gagliardi G; Liedberg A; Lax I; Lee C; Levitt S; Lind B; Rutqvist LE
Radiother Oncol; 2000 May; 55(2):153-62. PubMed ID: 10799727
[TBL] [Abstract][Full Text] [Related]
19. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
[TBL] [Abstract][Full Text] [Related]
20. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
